Icon (ICLR) EPS (Basic) Growth (3y) (2012 - 2026)
Powered by 
Analysis
Icon (ICLR) EPS (Basic) Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.69 Bn | 40.61 Bn | 1.44 Bn | -3.09% |
| 2 | Medpace Holdings | 16.49 Bn | 15.99 Bn | 201.64 Mn | 29.15% |
| 3 | Charles River Laboratories International | 13.08 Bn | 12.89 Bn | 452.07 Mn | -26.17% |
| 4 | Icon | 12.93 Bn | 12.00 Bn | 479.29 Mn | -6.13% |
| 5 | Fortrea Holdings | 1.61 Bn | 1.44 Bn | 139.20 Mn | -40.99% |
| 6 | Evotec SE | 625.08 Mn | 199.20 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 418.52 Mn | 333.98 Mn | 18.44 Mn | 40.58% |
| 8 | Champions Oncology | 72.88 Mn | 72.88 Mn | 7.03 Mn | 36.59% |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn | 38.73% |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6.13% |
| Mar 31, 2026 | -12.36% |
| Dec 31, 2025 | -11.73% |
| Sep 30, 2025 | 1.20% |
| Jun 30, 2025 | 16.27% |
| Mar 31, 2025 | 14.68% |
| Dec 31, 2024 | 29.26% |
| Sep 30, 2024 | 55.84% |
| Jun 30, 2024 | 25.16% |
| Mar 31, 2024 | 12.72% |
| Dec 31, 2023 | 7.52% |
| Sep 30, 2023 | 13.58% |
| Jun 30, 2023 | 39.57% |
| Mar 31, 2023 | 32.91% |
| Dec 31, 2022 | 10.24% |
| Sep 30, 2022 | 10.47% |
| Jun 30, 2022 | -0.03% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | -9.65% |
| Sep 30, 2021 | -43.56% |